Article
Current Landscape of iPSC Haplobanks
14 Sept 2024
Abstract excerpt
The use of allogeneic induced pluripotent stem cell (iPSC)-derived cell therapies for regenerative medicine offers an affordable and realistic alternative to producing individual iPSC lines for each patient in need. Human Leukocyte Antigens (HLA)-homozygous iPSCs matched in hemi-similarity could provide cell therapies with reduced immune rejection covering a wide range of the population with a few iPSC lines....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
